Correction of Psoriatic T Cell Signatures by Deucravacitinib
Abroad (travel likely)RecruitingPHASE4
Conditions
Psoriasis Vulgaris
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, San Francisco, San Francisco, California, United States
Study leads
Raymond Cho, MD, PhD
Principal Investigator
University of California, San Francisco